Neothetics (NEOT) Priced

Developing an injectable version of an approved asthma drug to reduce belly fat.

Health Care - Biotechnology

IPO Performance
Latest Trade $1.60 0.00 (0.0%)
First Day Return -14.3%
Return from IPO -88.6%
 
Neothetics IPO News more
  • .
IPO Data
IPO File Date 10/17/2014
Offer Price $14.00
Price Range $13.00 - $15.00
Offer Shares (mm) 4.7
Deal Size ($mm) 65
 
IPO Data
IPO Date 11/19/2014
Offer Price $14.00
Price Range $13.00 - $15.00
Offer Shares (mm) 4.7
Deal Size ($mm) $65
 
Underwriters
more
Business Overview
Developing an injectable version of an approved asthma drug to reduce belly fat.
Developing an injectable version of an approved asthma drug to reduce belly fat.
more
Company Data
Headquarters San Diego, CA
Founded 2007
Employees 9
Website www.neothetics.com
 

Performance vs. IPO Index (IPOUSA)